PGHH Holds 61st AGM, Reports 3% Sales and 7% PAT Growth for FY25 (9-month period)
The announcement details the routine proceedings of the AGM but also includes positive financial performance metrics for the recent fiscal year and long-term trends, which are material for investors.
The company reported positive sales and PAT growth for the 9-month fiscal year 2024-25, alongside strong long-term trends in sales, PAT, and ROE, and significant productivity savings.
* Procter & Gamble Hygiene and Health Care Limited (PGHH) conducted its 61st Annual General Meeting (AGM) on September 4, 2025, through Video Conferencing/Other Audio Visual Means. * Mr. Gurcharan Das, Independent Director, chaired the meeting in the absence of Mr. Chittranjan Dua. * Key resolutions passed included the adoption of financial statements for the fiscal year ended March 31, 2025, confirmation of interim dividend, declaration of final dividend, and the re-appointment of Ms. Sonali Dhawan as Non-Executive Director. * Special business included ratifying remuneration for the Cost Auditor for FY 2024-25, appointing M/s. M K Saraf & Associates LLP as secretarial auditors for five years, and re-appointing Mr. Chittranjan Dua and Mr. Krishnamurthy Iyer as Non-Executive Independent Directors for five years. * Mr. Kumar Venkatasubramanian, Managing Director, presented the company's financial performance and business strategy. * For the 9-month fiscal year 2024-25 (July 1, 2024, to March 31, 2025), the company reported a balanced growth with sales increasing by 3% and Profit After Tax (PAT) by 7% compared to the comparable 9-month period of the previous year. * Over the past 10 years (P10Y), the company demonstrated superior results, achieving a Net Sales CAGR of +6% and PAT CAGR of +8%, alongside a 3X increase in Return on Equity (ROE). * The company achieved ₹93 crore in productivity savings for FY 24/25. * The integrated growth strategy emphasizes portfolio performance, superiority, productivity, constructive disruption, and an empowered, agile, and accountable organization. * The results of the e-voting will be announced within two working days after the meeting.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under agm-egm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.